You are here

  • Home
  • Archive
  • Volume 7, Issue 3
  • Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider

Article info

Article menu

Download PDFPDF

Infections
Original research
Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider

Authors

  • Alessia Alunno Internal Medicine and Nephrology Unit, Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila, Italy PubMed articlesGoogle scholar articles
  • Aurélie Najm Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK PubMed articlesGoogle scholar articles
  • Xavier Mariette Department of Rheumatology, Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, INSERM UMR1184, Le Kremlin-Bicêtre, France PubMed articlesGoogle scholar articles
  • Gabriele De Marco Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & The NIHR Leeds Biomedical Research Centre, Chapel Allerton Hospital, Leeds, UK PubMed articlesGoogle scholar articles
  • Jenny Emmel Library & Evidence Research Centre, Medical Education, Leeds Teaching Hospitals NHS Trust, Leeds UK, Leeds, UK PubMed articlesGoogle scholar articles
  • Laura Mason Library & Evidence Research Centre, Medical Education, Leeds Teaching Hospitals NHS Trust, Leeds UK, Leeds, UK PubMed articlesGoogle scholar articles
  • Dennis G McGonagle Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & The NIHR Leeds Biomedical Research Centre, Chapel Allerton Hospital, Leeds, UK PubMed articlesGoogle scholar articles
  • Pedro M Machado National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC), University College London Hospitals (UCLH) NHS Foundation Trust, London, UKDepartment of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UKCentre for Rheumatology & Department of Neuromuscular Diseases,University College London, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Alessia Alunno; alessia.alunno82{at}gmail.com
View Full Text

Citation

Alunno A, Najm A, Mariette X, et al
Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider
RMD Open 2021;7:e001899. doi: 10.1136/rmdopen-2021-001899

Publication history

  • Received August 26, 2021
  • Accepted October 12, 2021
  • First published November 1, 2021.
Online issue publication 
July 06, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.